-
Prospective and External Validation of an Ensemble Learning Approach to Sensitively Detect Intravenous Fluid Contamination in Basic Metabolic Panels Clin. Chem. (IF 7.1) Pub Date : 2024-11-15 Nicholas C Spies, Leah Militello, Christopher W Farnsworth, Joe M El-Khoury, Thomas J S Durant, Mark A Zaydman
Background Intravenous (IV) fluid contamination within clinical specimens causes an operational burden on the laboratory when detected, and potential patient harm when undetected. Even mild contamination is often sufficient to meaningfully alter results across multiple analytes. A recently reported unsupervised learning approach was more sensitive than routine workflows, but still lacked sensitivity
-
Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Sharri S Cyrus,Michelle L Kluge,Cherisse A Marcou,Erik C Thorland,Vivek N Iyer,Linnea M Baudhuin
-
Commentary on Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Anne B S Giersch
-
Estimating Reference Change Values Using Routine Patient Data: A Novel Pathology Database Approach Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Eirik Åsen Røys, Kristin Viste, Ralf Kellmann, Nora Alicia Guldhaug, Bashir Alaour, Marit Sverresdotter Sylte, Janniche Torsvik, Heidi Strand, Michael Marber, Torbjørn Omland, Elvar Theodorsson, Graham Ross Dallas Jones, Kristin Moberg Aakre
Background The reference change value (RCV) is calculated by combining the within-subject biological variation (CVI) and local analytical variation (CVA). These calculations do not account for the variation seen in preanalytical conditions in routine practice or CVI in patients presenting for treatment. As a result, the RCVs may not reflect routine practice or align with clinicians’ experiences. We
-
dmTGS: Precise Targeted Enrichment Long-Read Sequencing Panel for Tandem Repeat Detection Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Kang Yang, Yue Liu, Ji Zhang, Qian Yu, Feng Xu, Jiyuan Liu, Yuting Li, Xiaojie Zhang, Zhiqiang Wang, Ning Wang, Yuezhen Li, Yan Shi, Wan-Jin Chen
Background Tandem repeats (TRs) are abundant in the human genome and associated with repeat expansion disorders. Our study aimed to develop a tandem repeat panel utilizing targeted long-read sequencing to evaluate known TRs associated with these disorders and assess its clinical utility. Methods We developed a targeted long-read sequencing panel for 70 TR loci, termed dynamic mutation third-generation
-
Adiponectin and Risk of Psoriasis: Observational and Mendelian Randomization Studies in up to 900 000 Individuals Clin. Chem. (IF 7.1) Pub Date : 2024-10-31 Maria B Nielsen, Marianne Benn, Børge G Nordestgaard, Lone Skov, Yunus Çolak
Background Psoriasis is a chronic inflammatory skin disorder often associated with obesity. Adiponectin, an anti-inflammatory protein-hormone secreted by adipose tissue, may be a link between obesity and psoriasis. We hypothesized that low plasma adiponectin is associated with an increased risk of psoriasis in observational and causal genetic studies. Methods In observational analyses, we used information
-
Forever Chemicals, Endless Testing? Expert Advice to Be Prepared for Per- and Polyfluoroalkyl Substances. Clin. Chem. (IF 7.1) Pub Date : 2024-10-29 Frederick G Strathmann,Susan Burden,Jenna Hua,Andrew Patterson,Robert Middleberg
-
Rethinking Albuminuria in Low-Risk Patients and a Call for Urine Albumin Standardization. Clin. Chem. (IF 7.1) Pub Date : 2024-10-28 Jesse C Seegmiller,Joachim H Ix
-
Machine Learning-Based Detection of Bladder Cancer by Urine cfDNA Fragmentation Hotspots that Capture Cancer-Associated Molecular Features Clin. Chem. (IF 7.1) Pub Date : 2024-10-21 Xiang-Yu Meng, Xiong-Hui Zhou, Shuo Li, Ming-Jun Shi, Xuan-Hao Li, Bo-Yu Yang, Min Liu, Ke-Zhen Yi, Yun-Ze Wang, Hong-Yu Zhang, Jian Song, Fu-Bing Wang, Xing-Huan Wang
Background cfDNA fragmentomics-based liquid biopsy is a potential option for noninvasive bladder cancer (BLCA) detection that remains an unmet clinical need. Methods We assessed the diagnostic performance of cfDNA hotspot-driven machine-learning models in a cohort of 55 BLCA patients, 51 subjects with benign conditions, and 11 healthy volunteers. We further performed functional bioinformatics analysis
-
Mass Spectrometry Meets Free Light Chains: A Path toward Greater Diagnostic Precision. Clin. Chem. (IF 7.1) Pub Date : 2024-10-17 Maria Alice Vieira Willrich
-
Correction to: Ready, Set, Screen: The Role of the Clinical Laboratory in Eliminating Chronic Hepatitis B Infection. Clin. Chem. (IF 7.1) Pub Date : 2024-10-17
-
Proteomic Signature of BMI and Risk of Cardiovascular Disease Clin. Chem. (IF 7.1) Pub Date : 2024-10-11 Hao Ma, Xuan Wang, Yoriko Heianza, JoAnn E Manson, Lu Qi
Background Obesity, defined by body mass index (BMI) alone, is a metabolically heterogeneous disorder with distinct cardiovascular manifestations across individuals. This study aimed to investigate the associations of a proteomic signature of BMI with risk of major subtypes of cardiovascular disease (CVD). Methods A total of 40 089 participants from UK Biobank, free of CVD at baseline, had complete
-
Deconvolution of Human Urine across the Transcriptome and Metabolome. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Sevahn K Vorperian,Brian C DeFelice,Joseph A Buonomo,Hagop J Chinchinian,Ira J Gray,Jia Yan,Kathleen E Mach,Vinh La,Timothy J Lee,Joseph C Liao,Richard Lafayette,Gabriel B Loeb,Carolyn R Bertozzi,Stephen R Quake
BACKGROUND Early detection of the cell type changes underlying several genitourinary tract diseases largely remains an unmet clinical need, where existing assays, if available, lack the cellular resolution afforded by an invasive biopsy. While messenger RNA in urine could reflect the dynamic signal that facilitates early detection, current measurements primarily detect single genes and thus do not
-
Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry. Clin. Chem. (IF 7.1) Pub Date : 2024-10-08 Priscilla S W Yeung,Yajing Liu,Samuel Yang,Ashley Ruan,Christina R Kerr,Carolyn V Wong,Run-Zhang Shi,David J Iberri,Ruben Y Luo
BACKGROUND Serum free light chains (FLCs) are an essential clinical biomarker for the diagnosis and monitoring of patients with plasma cell neoplasms. The current widely used immunoassay methods quantify total serum FLCs, which include monoclonal FLCs as well as FLCs in the polyclonal background. Patients with chronic diseases, inflammatory disorders, or renal dysfunction can have elevated total FLCs
-
Beyond the Screen-Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects. Clin. Chem. (IF 7.1) Pub Date : 2024-10-04 Christina C Pierre,Dina N Greene,Daniel S Herman,Octavia M Peck Palmer,Shani Delaney
-
In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects. Clin. Chem. (IF 7.1) Pub Date : 2024-10-04 Geralyn Messerlian,Glenn E Palomaki
-
Untargeted Metabolomics for Inborn Errors of Metabolism: Development and Evaluation of a Sustainable Reference Material for Correcting Inter-Batch Variability Clin. Chem. (IF 7.1) Pub Date : 2024-10-04 Rafael Garrett, Adam S Ptolemy, Sara Pickett, Mark D Kellogg, Roy W A Peake
Background Untargeted metabolomics has shown promise in expanding screening and diagnostic capabilities for inborn errors of metabolism (IEMs). However, inter-batch variability remains a major barrier to its implementation in the clinical laboratory, despite attempts to address this through normalization techniques. We have developed a sustainable, matrix-matched reference material (RM) using the iterative
-
Alzheimer Disease Blood-Based Biomarkers: Translation from Research into Clinical Use. Clin. Chem. (IF 7.1) Pub Date : 2024-11-04 Lance A Ladic,Mari L DeMarco,Nicholas J Ashton,Andrew J Saykin,Louis B Jacques
-
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Adrienne Savant
-
ADLM 2024 Annual Scientific Meeting Abstracts: Bold Advancements in Laboratory Medicine. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Christina C Pierre,Joshua Hayden,Mark A Marzinke
-
Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Sean T Campbell
-
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Mark A Cervinski
-
An Interference That Makes You Blue? Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Ruth Melka,Christopher W Farnsworth,Yanchun Lin
-
Personalized Reproductive Hormone Monitoring in Sweat. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Robert D Maynard
-
Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clin. Chem. (IF 7.1) Pub Date : 2024-10-03 Lucille De Maria,Marion Marlinge,Melisande Baravalle,Jean-Christophe Dubus,Julien Fromonot
-
B-195 Accelerating Molecular Diagnostics: Development of a novel Rapid, Integrated PCR System for Acute Respiratory Infections Detection Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 T Ma, L Dong, H Chen, Z Lv, J Chen, Y Yang
Background The COVID-19 pandemic and acute respiratory infections have underscored the necessity for high-throughput and timely molecular diagnostics. Existing molecular diagnostic methods are labor-intensive, a challenge particularly evident in large-scale testing. This study aims to streamline the nucleic acid testing process by integrating extraction and detection in PCR testing, thereby optimizing
-
B-316 Evaluation of an FDA-cleared Chromogranin A Assay on an Automated Analyzer Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 N Boyert, G Schroeder, M Dee, J M Colon-Franco
Background Chromogranin A (CgA) is a hydrophilic and acidic protein, present in the chromaffin granules of neuroendocrine cells. It is the preferred tumor marker for the monitoring of neuroendocrine tumors (NETS), which are often found in the lungs, appendix, pancreas, and gastrointestinal tract. Previous CgA assays were performed by manual ELISA testing, and were not FDA-approved, leading to a longer
-
B-205 Performance of a Novel Fluorogenic Assay for Detection of Carbapenemase-producing Enterbacteriaceae Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z Zhou, S Li, D Jiang, Z Wang, Y Wang, Y Zhang, H Wang, Y Su
Background In recent years, under the selective challenge of antibiotics, the variety and number of drugresistant pathogenic microorganisms have increased significantly, which brings great challenges to clinical diagnosis and treatment, especially the infection caused by carbapenem resistant Enterobacteriaceae (CRE). Carbapenemases production is the main mechanism of drug resistance of Enterobacteriaceae
-
B-200 Expediting Identification of Occult Sepsis with a Novel Diagnostic for Patients Presenting to the ED with Possible Infection Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 T Jagneaux, A Grantham, K Richard, C Thomas, C D’Antonio, M Laperouse, R Scoggins, H O’Neal
Background In August 2023 Our Lady of the Lake Regional Medical Center implemented a process for sepsis care based on a novel sepsis diagnostic (IntelliSep) in the Emergency Department (ED). As a component of our Sepsis Learning Health Program, we continually evaluate this process. Methods A nurse-driven protocol allows for IntelliSep ordering with triage assessment. Dependent upon bed availability
-
B-170 Age-Specific reference intervals for ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 I De Biase, M Miller, L M Zuromski, S Steckel, P P Vachali, T Yuzyuk
Background Plasmalogens are critical membrane structural components that are mainly generated by de novo synthesis starting in peroxisomes. Hence, patients with defects in peroxisome biogenesis (PBD) exhibit markedly reduced plasmalogen levels. Plasmalogen ratios are traditionally measured by gas chromatography-mass spectrometry (GC-MS); however, this method entails a lengthy sample extraction and
-
B-131 The fallacy of average sigma levels from mixed sample levels Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z BROOKS
Background Sigma measures the number of SDs (z-value) from the existing sample mean to the nearest analytical performance standard or allowable error limit. Authors and software programs often measure sigma metrics for each QC sample but use an average sigma to compare methods and select QC strategies. That practice leads to dramatic over or under-estimation of the number of errors reported and the
-
B-119 Comparative performance of GPT-4 and CNV-ETLAI in extracting copy number variations from medical journals: Bridging the gap between large language models and specialized NLP tools in genomic data interpretation Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 J Choi
Background Copy Number Variations (CNVs) are critical genetic markers in diversity and disease, yet their accurate extraction from medical literature remains challenging due to the complexity of genetic data. While specialized NLP models like CNV-ETLAI have been developed for this task, the advent of Large Language Models (LLMs) such as GPT-4 presents a potential alternative with broader applicability
-
B-068 Plasma calprotectin as an index of draining tunnel formation in Hidradenitis suppurativa Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 A Havelka, T Kanni, E J Giamarellos-Bourboulis
Background Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease which affects areas rich in apocrine glands. The main disease manifestations are inflammatory nodules (IN) and draining tunnels (dT). The course and progression of the disease are difficult to predict. There is currently lack of any broadly accepted biomarker which may inform on the activity of hidradenitis suppurativa
-
B-169 Combining the EXENT System and LC-MS for the Detection of Monoclonal Immunoglobulins at Low Levels Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 D R Barnidge, D Troske, S North, G Wallis, M Perkins, S Harding
Background The EXENT® system is an automated platform designed to quantify monoclonal immunoglobulins in serum. EXENT® combines immunoprecipitation and MALDI-TOF mass spectrometry for the detection of monoclonal immunoglobulins at levels lower than traditional gel based methods. This study was designed to demonstrate if EXENT® prepared samples that were negative could be reflexed to a more sensitive
-
B-179 Comparative Evaluation of Cisplatin Release from Alginate Hydrogels with Embedded Silver Nanoparticles: An HPLC and Colorimetric Spectrophotometry Study Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 H Kalil, S Maher, M Bayachou
Background Cisplatin [cis-dichlorodiamine platinum (II)], is a well-recognized chemotherapeutical drug. Cisplatin has been employed in treating a wide range of human cancers, such as those of the breast, bladder, lung, ovarian, and testicular cancers. Its therapeutic action is attributed to its capacity to form crosslinks with the DNA's purine bases, disrupting DNA repair processes, causing DNA damage
-
A-345 Effect of Hemolysis on Routine Blood Gas Analytes Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 B Agana, B Overton, K Florendo, C Knezevic
Background Hemolysis is a major pre-analytical concern for most laboratory analytes. Detection of hemolysis and mitigation efforts are especially important for analytes, such as potassium, with high intracellular concentrations. Routine serum and plasma chemistry tests are performed on analyzers with the capacity to detect and measure the degree of hemolysis. However, for whole blood chemistries and
-
A-296 Streck Urine Preserve Provides Sample Stability for Cepheid Xpert CT/NG test Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 C M Connelly, J Li
Background Sexually transmitted infections (STIs) are one of the most common communicable diseases worldwide and are associated with significant morbidity and mortality. Data indicates that the four curable STIs - chlamydia, gonorrhea, trichomoniasis, and syphilis - cause over 375 million infections annually. Further, the infection rate for gonorrhea has increased by 63% in the United States and the
-
A-331 Monitoring Operators Proficiency at Point of Care is Crucial for Reliable Patient Values. A Practical Example with Patient Blood Chloride, Potassium and Sodium Measurands Assayed with i-STAT® Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 V Genta, C M Aston, F M Alferes, P M Darville, S Shumate
Background While i-STAT® cartridges offer the Physician a spectrum of analytical methods at the point of care for prompt diagnosis and interventions, these methods have to be harmonized with the laboratory methods in order to reliably detect shifts and trends. With this practical example we illustrate the importance of a program of routine comparisons between the i-STAT® and laboratory methods to detect
-
A-319 Capillary Blood Collection for Egg-cellent Reproductive Insights Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 W C Brandon, B B Collier, M R Chappell, G Iacovetti, M Peevler, U Y Schaff, G J Sommer, R P Grant
Background In the United States, an estimated 13% of women between the ages of 15 and 49 years, experience impaired reproductive potential (fecundity). Assessment of fecundity typically requires an in-person physician visit and venous blood collection to evaluate hormone levels and identify potential reproductive health conditions. Exploring less invasive, at-home sampling options could offer couples
-
A-302 Evaluation of real-time PCR assays for detection of sexually-transmitted infections Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 H Soong
Background Sexually transmitted infections (STIs) have serious negative consequences for reproductive health worldwide. They are associated with infertility, premature birth and neonatal infections. Five STI pathogens, namely Trichomonas vaginalis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum were selected for the evaluation of three potential real-time PCR
-
A-205 Evaluating the Cost and Importance of Supply Chain Resilience in the Clinical Laboratory Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 E Jurinic
Background Recent pandemics, epidemics and outbreaks continually underscore the critical importance of resilient supply chains in healthcare, particularly in clinical laboratories where timely access to supplies is essential for patient care. Supply chain disruptions, whether due to global crises or localized challenges, can significantly impact laboratory operations, leading to delayed diagnoses,
-
B-244 Analytical Performance and Method Comparison Evaluation of a New High Throughput Fully Automated Plasma GFAP Immunoassay Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z Vucetic, M Szabo, M Salvati, B Schlichtmann, J Patzlaff, D Unruh, K Curtis, L Mediger, M Nichkova-Doseva
Background Glial Fibrillary Acidic Protein (GFAP) levels are shown to be an indicator of neurologic injury in conditions like Traumatic Brain Injury (TBI) and stroke and as a marker of disease progression in neuromuscular disorders such as multiple sclerosis. Plasma GFAP is also implicated in detecting AD pathology, correlating to the clinical stage of the disease. The performance characteristics of
-
A-237 Analytical Performance Evaluation of Cytomegalovirus IgG and Syphilis Assays on the Atellica CI Analyzer Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 M Quintanilla, B Valdivia, L Halik, G Arrode-Bruses, H Leipold
Background The Atellica® CI Analyzer is an automated, high-throughput integrated chemistry and immunoassay analyzer utilizing both Atellica® CH and Atellica® IM Assays. This study evaluated the analytical performance of the Atellica IM Cytomegalovirus IgG (CMV IgG) and Syphilis (Syph) Assays on the Atellica CI Analyzer. Methods Precision studies were performed according to CLSI EP05-A3 using native
-
A-171 Novel Fluorometric Assay for Pediatric Anti-Factor Xa Testing: Minimizing Bilirubin and Hemolysis Interference in Whole Blood Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 V Pamula, M Basmajian, A Ullal, L Nichols, S Adhikari, M Moser, S Emani, S Emani
Background High bilirubin levels are common in pediatric patients and are noted in patients undergoing extracorporeal membrane oxygenation (ECMO). Acute anticoagulation therapy necessitates frequent monitoring of anti-Factor Xa activity (aFXa), and high bilirubin levels cause interference in chromogenic assays. Moreover, large volumes of blood lead to iatrogenic anemia in pediatric and neonatal patients
-
B-263 Analytical Performance Evaluation of Eleven Drug of Abuse Assays on the Atellica CI Analyzer Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 S Lewisch, P Gupta, W Varhue, G Arrode-Bruses, J Snyder
Background The Atellica® CI Analyzer is an automated, high-throughput integrated chemistry and immunoassay analyzer utilizing both Atellica® CH and Atellica® IM Assays. This study evaluated the analytical performance of the Atellica CH Amphetamines (Amp), Barbiturates (Brb), Benzodiazepine (Bnz), Cannabinoids THC (Thc), Cocaine Metabolite (Coc), Ecstasy (Xtc), Methadone (Mdn), Opiates (Op), Oxycodone
-
B-168 Development and Validation of a Quantitative Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight (UPLC-QToF) Method for Urine Organic Acid Analysis Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Y Xiao, M Wakefield, M Gabra, E Leung
Background Urine organic acid (UOA) analysis is essential for the diagnosis of inborn errors of metabolism (IEMs). Traditionally, UOA analysis is performed with gas chromatography-mass spectrometry (GC-MS) and requires time-consuming sample preparation steps including liquid-liquid extraction and derivatization. The rapid development of Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry
-
B-194 Validation of a Diagnostic Test for the p.R337H Variant in the TP53 Gene by Nanopore Sequencing: Development of a Simplified Analysis Pipeline Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 M Andrade, A Belmok, L Silva, A Vieira, C Sousa, L Velasco, R Jácomo
Background The genetic variant p.R337H in the TP53 gene is a pathogenic variant associated with Li-Fraumeni Syndrome and an increased risk of developing various types of cancer, including breast cancer. This variant is present in about 1 in every 300 individuals in the Southern region of Brazil, likely due to a founder effect. Amplicon sequencing via the Sanger methodology remains prevalent for the
-
B-262 Validation of a point-of-care lateral flow immunoassay for urine drug testing prior to application in an outpatient rapid access addiction medicine clinic Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 M Bohn, S Delaney, B Jung, W Lamb, F Leung
Background Point-of-care (POC) urine drug testing is a useful adjunct to self-reporting in rapid access addiction medicine settings to immediately guide patient management. However, available POC immunoassays have limitations including cross-reactivity with unrelated compounds or low sensitivity that may cause false results. Here, we assessed the performance of a multi-drug test panel by comparing
-
B-333 Optimizing AFP Cutoffs for Hepatocellular Carcinoma Screening: Insights from the National Cancer Screening Program in Korea Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Y Choi, S Kim, H Kim, H Jeong, H Lee, W Lee, S Chun
Background The incidence rate and mortality rate of liver cancer were 11.6 (ranked 8th among cancers) and 10.7 (4th) per 100,000 individuals respectively globally in 2020, whereas in Korea, they were higher at 29.5 (7th) and 20.6 (2nd) per 100,000 individuals. The National Cancer Screening Program (NCSP) in Korea conducts biannual concurrent liver ultrasound and serum alpha-fetoprotein (AFP) measurement
-
A-104 Study of the matrix effect for thyroglobulin and calcitonin in fine-needle aspiration of cervical nodules Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 D Canali, G Zampieri, C Bonato, G Francisco, C Sabino, V Oliveira, A Lopes
Background Analysis of material from fine needle aspiration of cervical thyroglobulin nodules with Beckman Coulter reagents on the ACCESS equipment and Calcitonin using the Siemens reagent on the Immulite equipment. The matrix effect, linearity and the limit of analytical sensitivity were analyzed. This study aims to analyze the correlation between the serum/plasma results described in the suppliers'
-
A-088 Clinically Significant Errors Using the Diazyme Total Bile Acid Assay on the Roche c502 Analyzer: Investigating a Result Error Identifies a Novel Large-Scale Testing Error Caused by Reagent Carryover Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 L M Leonard, M A Nicklas, D R Block, N A Baumann
Background Thoroughly investigating single patient result errors may identify systemic, large-scale testing errors. The laboratory observed an event where a revision to a Total Bile Acid (TBA, Diazyme Laboratories, Inc.) patient result following a 22S quality control (QC) failure displayed a larger than expected difference (52 to 5mcmol/L). TBA is primarily used for diagnosis and monitoring of intrahepatic
-
B-133 Uric acid: A description of the values found in adult patients treated during 2022 in a High Complexity Hospital Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 A I Corominas, G Casal, F Vommaro, S Balconi, A Damiano
Background An association between uric acid and kidney disease, glucose intolerance, high blood pressure, metabolic syndrome and cardiovascular disease has been recognized. It is the obligation of the Clinical Laboratory to have valid reference intervals (RI) for this marker. Each particular population has genetics and a diet that represents it, which cannot be extrapolated in many cases. The difficulty
-
B-184 Purifying High-Quality Genomic DNA From Frozen Blood Samples Stored up to 1.5 Years at -20°C Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 A Wood, Y Wang
Background Maintaining DNA integrity in blood samples, from transport to storage to processing, is crucial to the success of downstream applications, especially regarding diagnostic applications. Additionally, due to the invasive nature of collecting blood samples, minimizing resampling to avoid excess patient pain and cost of collection and transportation are important to consider. Having the option
-
B-047 A Rapid Host-Response Test Supports Antimicrobial Stewardship at a Micro-Hospital Emergency Department Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 B DuChateau, S Murphy, C Tarr, T Gottlieb, S Spies
Background The management of patients with suspected infections requires identification of the infectious etiology to determine appropriate use of antibiotics. However, differentiating viral from bacterial infection (and co-infection) is often challenging as clinical presentations can be similar and existing diagnostics sometimes fail to identify a clinically relevant pathogen. A host-response test
-
B-036 Systematic Evaluation of Antibody-Antigen Interactions for Suitability in Immunoassays Using Parallel Microarray ELISA Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 M Coolen, K M van Ham, T J Schulte, G Schilders
Background A critical step in immunoassay development is the selection of the appropriate capture and detection antibodies. The use of suboptimal antibodies can drastically affect the quality of the final assay. Traditional selection methods involve a direct testing of potential antibodies in the final assay setting; a time-consuming and material-intensive exercise that is often too complex to test
-
A-192 Effectiveness in Communicating Critical Results: impact of technology and consultive actions on improving performance indicators in a laboratory in Northeast Brazil Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 R Pena, G Ribeiro, J Silveira, V Braid, S Viana
Background Critical results consist of laboratory test results that require immediate intervention or decision-making by the responsible medical team, as they pose a risk to the patient's life. To manage the process of communicating critical results, it is also necessary to define the indicators, goals and systematic comparability through benchmarking. Methods The performance of the indicators measuring
-
A-116 Pleural Fluid pH - Are We Collecting and Measuring It Correctly? Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 C Tan, S Tan, S Chiong, C Yeo
Background Pleural fluid pH has diagnostic, therapeutic, and prognostic implications in the management of pleural space infections and malignancy. Pleural fluid sample collection, transportation and processing are known for source of pre-analytical error which contribute to inaccuracy of measured pH with clinical implication to patient care. Some clinical practices observed locally include pleural
-
A-107 Sample Matrix Matters: A Precision Study of BioRad, TechnoPath, and Patient Pooled Samples Across 20 High Volume Chemistries and Immunoassays Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 K Sobhani, A K Quizon, R Masukawa, C Hernandez, I Peteros, E Manimtim
Background BioRad is a major provider of QC materials in the US with robust peer data, and Technopath has emerged as a recent competitor, especially on cost. While many factors are considered when selecting QC materials, primary considerations include commutability, matrix effects, decision levels, and acceptability limits. A couple studies comparing BioRad and Technopath QC performance were published
-
A-082 Establishment of Infant Free T4 Reference Interval Through Indirect Methods Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 Z Wu, C Bi, E M Li, E I Schindler, M I Marcelli, E C Wong, N J Clarke
Background Children require reference intervals distinct from adults and, based on their unique developing physiology, several intervals are often required to accurately reflect the distribution of expected results in a healthy pediatric population. The establishment of pediatric reference intervals has proven challenging. While consenting adults volunteer to contribute their biological material towards
-
A-210 Ldl-c to non-hdl-c ratio method: a simple way to determine bias for ldl-c methods on hypertriglyceridemic samples Clin. Chem. (IF 7.1) Pub Date : 2024-10-02 T A Gcingca, M Sampson, J W Meeusen, L J Donato, A S Jaffe, A T Remaley
Background Beta-quantification (BQ) is the reference method for LDL-C but is not widely available. It is difficult, therefore, for clinical laboratories to independently assess the accuracy of their methods for either calculating or directly measuring LDL-C. Our goal was to investigate if an interrelationship between the tests in the standard lipid panel could be used to compare the performance of